Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461212 · ClinicalTrials.gov registry record · NA
Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02461212: Completed NA study, sponsored by Emory University.
NCT02461212 is a NA study that has completed, run by Emory University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02461212, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the HepaFat-Scan (a special sequence of images done in a MRI) can accurately detect the amount of fat in the liver.
Primary Outcome
Correlation of histologic steatosis to HepaFat-Scan measurement.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2017-03-17 |
| Phase | NA |
What the finished NCT02461212 record still lists
NCT02461212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02461212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02461212 about?
NCT02461212 is a clinical study titled "Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth". The purpose of this study is to see if the HepaFat-Scan (a special sequence of images done in a MRI) can accurately detect the amount of fat in the liver.
What is the current status of trial NCT02461212?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-07-01. Estimated completion is 2017-03-17.
What interventions are being tested in trial NCT02461212?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE).
Who is sponsoring clinical trial NCT02461212?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02461212's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI